Psychiatry

Prisma Health/University of South Carolina SOM Greenville (Greer) Program

Greer, SC · South Atlantic

🌍 J-1 VisaCategorical
YOUR FIT· Prisma Health/University of South Carolina SOM Greenville (Greer) Program

Create a free profile to see your personalized fit

Get Started

Applicant Profile

2025 Data

What successful applicants at this program look like

See how competitive you are here

Compare your stats against applicants at Prisma Health

Create Free Account

Contact

JO
Program Director
Jessica Obeysekare, MD
no email on file
KP
Program Coordinator
Kerri Pellegrino, BS
Email coordinator

Training Sites

4 hospitals

  • 1
    Prisma Health Greer Memorial Hospital
    Greer, SC
    Primary
  • 2
    Prisma Health
    Columbia, SC
    Sponsor
  • 3
    Spartanburg Area Mental Health Center
    Spartanburg, SC
    Participant
  • 4
    The Carolina Center for Behavioral Health
    Greer, SC
    Participant

Score Ranges

USMLE Step 2 CK229262
180205230255280
COMLEX Level 2 CE446673
400500600700800

Interview Rates

US MD
17%
US DO
13%
US IMG
5%
Non-US IMG
1%

Applicant Origin

In-State
33%
Out-of-State
10%

Interview Prep

Common questions for Psychiatry interviews

specialtyWhat drew you to psychiatry?★ common
clinicalHow do you handle countertransference?
clinicalDescribe a patient interaction that was particularly meaningful.★ common
specialtyWhat population do you want to work with? (Child, geriatric, forensic, addiction)
clinicalHow do you approach the biological vs psychosocial model?
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common

Community Resources

Psychiatry applicant community for 2025-2026 cycle

Calculate your match probability for Psychiatry

See how your profile compares across all programs

Open Calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.